As part of our series of white papers tracking clinical trials activity around the world, GlobalData recently compiled a summary of clinical trial in Australia. GlobalData captured records of 3,199 clinical trials across all diseases and phases that had a start date January 01, 2012, and December 31, 2016.
The largest number of global clinical trials overall took place in non-small cell lung cancer, with 122 trials, followed by type 2 diabetes, hepatitis C, solid tumour, and breast cancer. Phase II was the most frequent phase across the major indications, as shown in Figure 1, ranging from 26–48% of trials for each indication. Phase III was the second most frequent phase, making up 54% of hepatitis C trials. Phase I made up the highest percentage in solid tumour trials.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
